The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on RBS's remaining State Aid obligation

20 Feb 2017 07:00

RNS Number : 2467X
Royal Bank of Scotland Group PLC
20 February 2017
 

The Royal Bank of Scotland Group plc

 

20 February 2017

 

Update on RBS's remaining State Aid obligation

 

RBS has been informed by HM Treasury ("HMT") that the Commissioner responsible for EU competition policy plans to propose to the College of Commissioners to open proceedings to gather evidence on an alternative plan for RBS to meet its remaining State Aid obligations. If adopted, this alternative plan would replace the existing requirement to achieve separation and divestment by 31 December 2017 of the business previously described as Williams & Glyn. As previously disclosed, none of the proposals to acquire the business received by RBS can deliver a full separation and divestment before the 31 December 2017 deadline. 

 

RBS has agreed that HMT will now seek formal amendment to RBS's State Aid commitments to pave the way for the Commissioner to propose to open proceedings, as described above. In addition to the Commission's proceedings, HMT will carry out a market testing exercise in parallel. The opening of the Commission's proceedings does not prejudge the outcome of the investigation.

 

The plan envisages that RBS will deliver the following revised package of remedies to promote competition in the market for banking services to small and medium enterprises ("SMEs") in the UK:

 

· A fund, administered by an independent body, that eligible challenger banks can access to increase their business banking capabilities;

· Funding for eligible challenger banks to help them incentivise SMEs to switch their accounts from RBS paid in the form of "dowries" to eligible challenger banks; 

· RBS granting business customers of eligible challenger banks access to its branch network for cash and cheque handling, to support the measures above; and 

· An independent fund to invest in fintech to support the business banking of the future.

Ross McEwan, RBS CEO, said "Today's proposal would provide a path to increased competition in the SME market place. If agreed it would deliver an outcome on our EC State Aid divestment obligations more quickly and with more certainty than undertaking a difficult and complex sale and would provide much needed certainty for customers and staff."

 

RBS has taken a £750 million provision within its 2016 Annual Results as a consequence of today's proposal. This represents our best estimate of the cost of the above package of remedies at this juncture.

 

Our Q3 2016 Financial Supplement disclosed a breakdown of Williams & Glyn's income and customer loans and advances between Retail and Commercial as set out in the table below.

 

Subject to the plan becoming finalised and further discussions with the EC and HMT we will assess the timing and manner in which we reincorporate the business into the RBS franchises. This reintegration would likely create some additional restructuring charges during 2017 and 2018.

 

RBS will be publishing its 2016 Annual Results on 24 February 2017.

 

For enquiries please contact:

 

Investor Relations

Alexander Holcroft

Head of Equity Investor Relations

+44 (0) 20 7672 1758

 

Matthew Richardson

Head of Fixed Income Investor Relations

+44 (0) 20 7678 1800

 

RBS Media Relations

+44 (0) 131 523 4205

 

Additional information:

 

Our Q3 2016 Financial Supplement disclosed a breakdown of Williams & Glyn's income and customer loans and advances between Retail and Commercial as set out in the table below

 

 

Segment Performance

 

 

 

 

 

Williams & Glyn

 

 

 

2015

2016

Q3 YTD

Q3 YTD

Income statement (1)

£m

£m

 

 

 

Analysis of income by product

 

 

Retail

355

351

Commercial

270

269

Total income

625

620

Analysis of impairments by sector

 

 

Retail

15

21

Commercial

(20)

10

Total impairment losses/(releases)

(5)

31

 

 

 

2015

2016

30 September

30 September

Balance sheet (1)

£bn

£bn

Loans and advances to customers (gross)

 

 

- Retail

11.4

12.2

- Commercial

8.9

8.6

Total loans and advances to customers (gross)

20.3

20.8

 

 

Note:

 

 Williams & Glyn refers to the business formerly intended to be divested as a separate legal entity and comprises RBS England and Wales branch-based businesses, along with certain small and medium enterprises and corporate activities across the UK.

 

 

This announcement Includes Inside information which is a disclosure required by the European Union Market Abuse Regulation EU 596/2014 of 16 April 2014. "Inside Information" is used as defined in that Regulation.

 

 

Forward-looking statements

 

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position and requirements, financial position, future pension funding requirements, on-going litigation and regulatory investigations, profitability, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "believes", "risk", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK Annual Report and Accounts and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFEIFTIALID
Date   Source Headline
30th Nov 20167:03 amRNSStatement re 2016 stress test results
22nd Nov 20163:35 pmRNSDividend Declaration
22nd Nov 20162:55 pmRNSPublication of Suppl.Prospcts
16th Nov 20166:00 pmRNSAllotment and Issue of New Ordinary Shares
9th Nov 20163:01 pmRNSDirector/PDMR Shareholding
8th Nov 20167:00 amRNSRBS Launches a New Complaints Process
31st Oct 20163:40 pmRNSTotal Voting Rights
28th Oct 20167:00 amRNSInterim Management Statement
6th Oct 20164:15 pmRNSBlock listing Interim Review
30th Sep 20161:37 pmRNSTotal Voting Rights
30th Sep 20167:00 amRNSProposed Future Ring Fenced Structure and Brands
28th Sep 20167:00 amRNSRBS Settles Certain RMBS Claims with the NCUA
27th Sep 20168:30 amRNSBank of America Merrill Lynch CEO Conference
12th Sep 20162:30 pmRNSBarclays Global Financial Services Conference
8th Sep 20167:00 amRNSRBSG priced $2.65 billion Senior Notes
2nd Sep 20165:44 pmRNSAllotment and Issue of new Ordinary shares
31st Aug 20162:43 pmRNSTotal Voting Rights
25th Aug 20167:02 amRNSDividend Declaration
25th Aug 20167:00 amRNSRedemption of USD Preference Shares Series R and T
23rd Aug 20163:00 pmRNSDirector/PDMR Shareholding
19th Aug 20162:15 pmRNSPublication of Suppl.Prospcts
11th Aug 20167:00 amRNSRBSG successfully priced $2.65bn Additional Tier
8th Aug 20163:30 pmRNSDirector/PDMR Shareholding
5th Aug 20167:00 amRNSHalf Year Report - Part 2
5th Aug 20167:00 amRNSHalf Year Report - Part 1
1st Aug 20167:07 amRNS2016 EBA EU-wide stress test results
29th Jul 20163:18 pmRNSTotal Voting Rights
21st Jul 20161:15 pmRNSVocaLink Holdings Limited Shareholding
30th Jun 20161:18 pmRNSTotal Voting Rights
29th Jun 20161:36 pmRNSHolding(s) in Company
27th Jun 20165:12 pmRNSDividend Declaration
24th Jun 201612:02 pmRNSPrice Monitoring Extension
9th Jun 20168:00 amRNSGoldman Sachs European Financials Conference
7th Jun 20165:30 pmRNSPublication of a Prospectus
1st Jun 20165:25 pmRNSNotification of Major Interest in Shares
31st May 20163:17 pmRNSTotal Voting Rights and Capital changes
26th May 20165:15 pmRNSDividend Declaration
24th May 20165:56 pmRNSAllotment and Issue of New Ordinary Shares
16th May 201610:00 amRNSAppointment of a Non-Executive Director
16th May 20167:07 amRNSNotices of Redemption
11th May 20163:39 pmRNSDirector/PDMR Shareholding
10th May 201612:40 pmRNSNotices of Redemption
4th May 20165:45 pmRNSResult of AGM
4th May 20161:55 pmRNSAGM Statement
29th Apr 20162:17 pmRNSTotal Voting Rights and Capital changes
29th Apr 20167:00 amRNSInterim Management Statement
28th Apr 20165:41 pmRNSRBS Holdings N.V. and Royal Bank of Scotland N.V.
28th Apr 20161:55 pmRNSUpdate on the disposal of Williams & Glyn
26th Apr 20164:04 pmRNSDividend Declaration
20th Apr 20163:03 pmRNSForm 8.3 - Electronic Data Processing plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.